Skip to content
Cryptos: 601Market Cap: $3.37T 1.2%24h Vol: $125.32BDominance: BTC 46.6% ETH 8.3%
Open Tradzy

Big move · Brazil stocks

IDEXX Laboratories, Inc. (I1DX34) surges 20.0% to BRL 744.09

Its biggest one-day rise in at least a year.

Published 3 November 2026 · Written from Tradzy's price and volume data

Close
BRL 744.09
On the day
+20.0%
Volume
no average yet
vs 52-week high
−8.5%

IDEXX Laboratories, Inc. closing prices

BRL 500.00BRL 600.00BRL 700.00Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26BRL 744.09

The last 90 closes up to 3 November 2026. The live chart is on the I1DX34 page.

What happened

IDEXX Laboratories, Inc. (I1DX34) closed at BRL 744.09 on 3 November 2026, up 20.0% from BRL 620.12 the session before.

It was I1DX34's biggest one-day rise in at least a year. Over 5 sessions the price is up 32.9%, and over 20 sessions it is up 38.3%.

The close is 8.5% below the highest close of the past year (BRL 813.60 on 28 Nov 2025) and 45.9% above the lowest (BRL 509.99 on 8 Oct 2026).

Across the 15 B3 stocks we track, 11 closed higher and 4 closed lower that day, with a median change of +0.98%. I1DX34's change was +20.0%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeBRL 620.12
CloseBRL 744.09
Change on the day+19.99%
Change over 5 sessions+32.87%
Change over 20 sessions+38.28%
Volume8.00
Average volume, up to 20 sessions beforenot enough history
Volume against that averagenot enough history
Highest close in the past yearBRL 813.60 (28 Nov 2025)
Lowest close in the past yearBRL 509.99 (8 Oct 2026)

The full chart and history are on IDEXX Laboratories, Inc. (I1DX34). More from this market: B3 news today.

More B3 moves on 3 November 2026

Want a plan for I1DX34? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.